Evidence map›Paper›PMID 17526946›Full record

ArticleEndocrine2006

Effects of estradiol-17beta on expression of mRNA for seven angiogenic factors and their receptors in the endometrium of ovariectomized (OVX) ewes.

Mary Lynn Johnson, Anna T Grazul-Bilska, Dale A Redmer, Lawrence P Reynolds

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Maternal obesity and overnutrition alter fetal growth rate and cotyledonary vascularity and angiogenic factor expression in the ewe.American journal of physiology. Regulatory, integrative and comparative physiology · 2010
    Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mary Lynn JohnsonDepartment of Animal and Range Sciences, Cell Biology Center, North Dakota State University, Fargo, ND 58105-5727, USA. mary.lynn.johnson@ndsu.edu
Anna T Grazul-Bilska
Dale A Redmer
Lawrence P Reynolds
North Dakota State University · US

Funding

THE MAJOR ANGIOGENIC FACTORS IN PLACENTAL ANGIOGENESIS.R01HL064141 · NHLBI · NORTH DAKOTA STATE UNIVERSITY · PI REYNOLDS, LAWRENCE P · 2001 to 2004
$589k
NCRR NIH HHS RR016741NHLBI NIH HHS R01HL64141
6 · The paper itself

Abstract

We have previously established an ovariectomized (OVX) ewe model to study how steroid removal and replacement affects uterine blood vessel and tissue growth. Using this model, endometrial expression of mRNA for 14 angiogenic factors (7 genes and their respective receptors) in caruncular (CAR) and intercaruncular (ICAR) endometrium were evaluated by quantitative real time RT-PCR at 0 (control), 2, 4, 8, 16, or 24 h after treating OVX ewes with an estradiol-17beta (E2) implant. In CAR and ICAR, compared to 0 h, the mRNA expression of vascular endothelial growth factor (VEGF), VEGF receptor (R)1, soluble guanylate cyclase (GUCY1B3; the R for nitric oxide [NO]), hypoxia inducible factor (HIF)1alpha, and placental growth factor (PlGF) increased by 4 h after E2-treatment, but basic fibroblast growth factor (FGF2), endothelial NO synthase (NOS3), angiopoietin (ANGPT)1, ANGPT2, ANGPT receptor Tie2 by 2 h after E2. Expression of mRNA for FGFR2 IIIc was increased at 2 h by E2-treatment in ICAR, but not in CAR. By contrast, expression of neuropilin (NP)1 mRNA was increased at 2 h in CAR, but not ICAR. The mRNA expression of VEGF, FGF2, HIF1 alpha, and PlGF was positively correlated with mRNA expression of NOS3, VEGFR1, and Tie2 suggesting some E2-stimulated interactions between these factors in promoting blood vessel growth. Thus, several major angiogenic factors and their receptors are increased within hours after E2-treatment, which indicates that E2 plays a role in regulation of angiogenesis in the uterus. By using the OVX ewe model, we may begin to understand the molecular basis of E2 effects on angiogenesis in the endometrium and, eventually, how angiogenesis is regulated in normal versus pathological conditions.

Indexed as

Angiogenic ProteinsAnimalsC-Reactive ProteinEndometriumEstradiolFemaleFibroblast Growth Factor 2Gene Expression RegulationGuanylate CyclaseHypoxia-Inducible Factor 1, alpha SubunitNerve Tissue ProteinsNitric Oxide Synthase Type IIIOvariectomyPentraxinsPlacenta Growth FactorPregnancy ProteinsAngiogenic ProteinsC-Reactive ProteinEstradiolFibroblast Growth Factor 2Guanylate CyclaseGUCY1B1 protein, humanHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitNerve Tissue ProteinsNitric Oxide Synthase Type IIIPentraxinsPGF protein, humanPlacenta Growth FactorPregnancy ProteinsReceptors, Cell SurfaceReceptors, Cytoplasmic and NuclearReceptor, TIE-2RNA, MessengerSoluble Guanylyl Cyclase

Identifiers

PMID17526946
OpenAlexW2050876005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.